Jerome Lambert
Overview
Explore the profile of Jerome Lambert including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
112
Citations
2335
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
21.
Lambert J, Di Blasi R, Rabian F, Dourthe M, Baruchel A, Thieblemont C, et al.
Hemasphere
. 2023 Jun;
7(6):e873.
PMID: 37260917
No abstract available.
22.
Vasseur L, Fenwarth L, Lambert J, de Botton S, Figeac M, Villenet C, et al.
Blood Adv
. 2023 May;
7(15):4024-4034.
PMID: 37205853
Whether the LSC17 gene expression can improve risk stratification in the context of next generation sequencing-based risk stratification and measurable residual disease (MRD) in patients with intensively treated AML has...
23.
Talbot A, Bobin A, Tabone L, Lambert J, Boccaccio C, Deal C, et al.
Haematologica
. 2023 Apr;
108(10):2774-2782.
PMID: 37078253
Belantamab mafodotin (BM) is an anti-BCMA antibody-drug conjugate (GSK2857916) that represents an alternative option in multiple myeloma. We sought to assess the efficacy and safety of BM in a real-world...
24.
Vanier A, Fernandez J, Kelley S, Alter L, Semenzato P, Alberti C, et al.
BMJ Evid Based Med
. 2023 Feb;
29(1):1-5.
PMID: 36788020
No abstract available.
25.
Bouhnik Y, Pineton de Chambrun G, Lambert J, Nachury M, Seksik P, Altwegg R, et al.
Clin Gastroenterol Hepatol
. 2023 Feb;
21(13):3365-3378.e5.
PMID: 36731588
Background & Aims: The management of intra-abdominal abscesses complicating Crohn's disease (CD) is challenging, and surgery with delayed intestinal resection is often recommended. The aims of this study were to...
26.
Lambert J, Lengline E, Porcher R, Thiebaut R, Zohar S, Chevret S
Blood Adv
. 2022 Dec;
7(19):5680-5690.
PMID: 36534147
For the past decade, it has become commonplace to provide rapid answers and early patient access to innovative treatments in the absence of randomized clinical trials (RCT), with benefits estimated...
27.
Pajot O, Lakhal K, Lambert J, Gros A, Bruel C, Boulain T, et al.
Antibiotics (Basel)
. 2022 Nov;
11(11).
PMID: 36421308
Background: Strong evidence suggests a correlation between pharmacodynamics (PD) index and antibiotic efficacy while dose adjustment should be considered in critically ill patients due to modified pharmacokinetic (PK) parameters and/or...
28.
Kraeber-Bodere F, Zweegman S, Perrot A, Hulin C, Caillot D, Facon T, et al.
Haematologica
. 2022 Oct;
108(2):621-626.
PMID: 36263839
No abstract available.
29.
Agbohessou P, Mandiki S, Mbondo Biyong S, Cornet V, Nguyen T, Lambert J, et al.
Fish Shellfish Immunol
. 2022 Aug;
128:620-633.
PMID: 36038101
This study aimed to determine to what extend the addition of chitinase to black soldier fly larvae (BSF) meals enriched with either PUFA or LC-PUFA could improve the gut health...
30.
Boschetti G, Nachury M, Laharie D, Roblin X, Gilletta C, Aubourg A, et al.
Am J Gastroenterol
. 2022 Aug;
117(9):1482-1490.
PMID: 35973142
Introduction: The objective of this study was to describe the efficacy and safety of infliximab (IFX) reintroduction in Crohn's disease (CD) after stopping for loss of response or intolerance. Methods:...